Skip to main content

Table 4 Perinatal outcomes and survivor' outcomes between amnioreduction (AR) and non-amnioreduction (non-AR)

From: Prognosis and long-term neurodevelopmental outcome in conservatively treated twin-to-twin transfusion syndrome

 

AR

non-AR

Pvalue

Number

26

16

NS

Gestational age at diagnosis (weeks)

25 (18-32)

23 (19-34)

NS

Gestational age at delivery (weeks)

28 (24-34)

27 (22-34)

NS

Diagnosis to delivery interval

(days)

22 (4-56)

30 (1-73)

NS

Birth weight (g)

1124 (335-2222)

921 (255-2138)

NS

IUFD

0

5 (31.2%)

NS

Neonatal death

10 (38.5%)

3 (27.3%)

NS

Infant death

1 (3.8%)

1 (9.1%)

NS

Lost to follow-up

2 (7.7%)

0

NS

Long-term survivors

13 (50%)

7 (63.6%)

NS

Neurodevelopmental impairment

3 (23.1%)

3 (42.9%)

NS

  1. Data shown as mean (range) or n (%) as appropriate.
  2. NS, not significant; IUFD, intrauterine fetal death.